Full range of Medcan Australia products available via BHC and CDA

This new order follows on from an initial trial order in late 2019

This article is from Project Herba for Health Care, Medical & Biotech

"Medcan Australia (Medcan) is pleased to announce the delivery of its full range of Medcan Australia branded products to Queensland based Burleigh Heads Cannabis (BHC). 

BHC will provide the Medcan Australia product offering to its existing network of national pharmacists and prescribing doctors including the CDA clinic (Cannabis Doctors Australia) medical team. 

This new order follows on from an initial trial order in late 2019 which saw BHC purchase MEDCAN NQ01 for release to market. 

Medcan’s range of products available through BHC and CDA include:

  • MEDCAN NQ01 - Dried Flower product – 13% THC 
  • MEDCAN CC01 - Dried Flower product – 21% THC 
  • MEDCAN FX01 - Cannabis Oil – 20mg/ml THC 
  • MEDCAN FX02 - Cannabis Oil – 5mg/ml THC, 8mg/ml CBD 
  • MEDCAN GC01 - Cannabis Capsules – 8mg THC 
  • MEDCAN GC02 - Cannabis Capsule – 5mg THC, 8mg CBD 

Doctors and Pharmacists Australia wide can now access Medcan Australia’s full range of medicinal cannabis products through Burleigh Heads Cannabis. 

Patients looking to source the full range of Medcan Australia branded Medicinal Cannabis products, can now contact CDA clinics for medical consultations and advice."

Please read the full announcement via the link below. 

Related Attachments

February 18th, 2020

Medcan Announcement 18 February 2020 ( 205.76 KB )